Regal Assets Analytics

Turning Point Trial Records Positive Results; Matinas’ Drug Does Not Prove Superiority

By |2021-02-01T11:49:26-05:00February 1st, 2021|Tags: , |

Turning Point Therapeutics, Inc (NASDAQ:TPTX) said over the weekend that the confirmed objective response rate (0RR) was 93% for the [...]

Turning Point to present data from lung cancer trial; SanaCurrents closing out Aurina

By |2021-02-01T11:02:57-05:00January 31st, 2021|Tags: , |

Data from Turning Point Therapeutics’ (NASDAQ:TPTX) phase II trial of repotrectinib in advanced non-small cell lung cancer (NSCLC) is scheduled [...]

Turning Point Therapeutics, Inc. (TPTX) Probability Sentiment

By |2020-08-11T08:46:56-04:00August 8th, 2020|Tags: |

Turning Point Therapeutics, Inc (NASDAQ:TPTX) Probability Sentiment FEATURED CATALYST SUMMARY Finding patients with specific genetic [...]

Go to Top